Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAS41002 lotion vs reference treatment for scalp psoriasis (Phase IIb, Germany)
2009-016261-28Phase 2Completed
- Sponsor
- Almirall
- Start
- Oct 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of mometasone in psoriasis (2 arms), sponsored by Almirall. Primary endpoint: Primary efficacy endpoint at week 3. Started Oct 2009; status: completed.
02
Drugs
mometasone
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2009-016261-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016261-28.